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In patients who develop early signs of fotocarcinogenesi,
the actinic keratosis are one of the most frequent events
that can lead to problems of therapeutic management,
especially if for business reasons or lifestyle, they are
repeatedly and chronically exposed to the sun. In these
patients the lesions are often widespread and recurrent,
and may require repeated treatment cycles.
It is in these cases that treatment with topical diclofe-
nac 3% gel hyaluronic acid can provide good results
thanks to its efficacy, tolerability, the patient compliance
and excellent cosmetic results compared to other con-
ventional therapies.
It presents a brief review of clinical cases with the
treatment modality and they discuss the indications and
efficacy.
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